Experience

Davis Polk is advising Sunac China Holdings Limited in connection with a proposed acquisition of shares in Kaisa Group Holdings Ltd. Pursuant to the terms of the share purchase agreement,…

Davis Polk advised Ultra Clean Holdings, Inc. (“UCT”) in connection with its approximately $43.6 million acquisition of Marchi Thermal Systems, Inc. The consideration consisted of $30…

Davis Polk is advising the administrative agent, and the lead arrangers and lead bookrunners, in connection with commitments for a senior unsecured bridge loan facility provided to American…

Davis Polk advised CAR Inc. in connection its 144A and Regulation S offering of $500 million 6.125% senior notes due 2020. The notes are guaranteed by certain offshore subsidiaries of CAR…

Davis Polk advised Corporación Inmobiliaria Vesta, S.A.B. de C.V. (Vesta) in connection with its offering of 124,274,111 shares of common stock for a total of approximately $230 million,…

Davis Polk advised Delhi International Airport Private Limited (DIAL), a corporation organized under the laws of the Republic of India, in connection with DIAL’s inaugural Regulation S…

Davis Polk advised McGraw Hill Financial, Inc. (“McGraw Hill”) and Standard & Poor’s Financial Services LLC (“Standard & Poor’s”) in connection with their recently announced…

Davis Polk is advising the administrative agent, and the sole lead arranger and sole bookrunner, in connection with a senior unsecured bridge financing for The J. M. Smucker Company’s…

Davis Polk advised the joint book-running managers and representatives of the underwriters on a public offering by Laboratory Corporation of America Holdings (LabCorp) of $500 million…

Davis Polk represents several current and former directors of Orexigen Therapeutics (the “Company”) in connection with derivative litigation relating to the award of equity compensation. On…